Progress in molecular biology and translational science · 2019
Computational prediction and redesign of aberrant protein oligomerization.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Santos Jaime, Iglesias Valentín, Ventura Salvador
Аннотация
Non-native intermolecular contacts often lead to aberrant protein oligomerization and aggregation. This phenomenon is behind the onset of several human disorders and is a bottleneck for the production of proteins of biotechnological interest. Intrinsically disordered proteins have evolved to avoid aberrant oligomerization, but mutations or aging-promoted degeneration of the protein quality machinery might result in their aggregation. Folded globular proteins are not completely protected from aggregation, mostly because the physicochemical properties stabilizing their tertiary and/or quaternary structures are very similar to those leading to non-native oligomerization. Once these properties are known, it becomes feasible to predict the aggregation propensities of proteins and to design them to disfavor aggregation-prone contacts. In this chapter, we describe how computational approaches can assist the identification of the aggregation-prone sequential or structural regions leading to aberrant oligomerization and how these tools can be employed to predict pathogenic mutations or to design biotherapeutics with optimized solubility.
Предметные рубрики MeSH
AlgorithmsAmyloid beta-PeptidesAnimalsComputational BiologyEvolution, MolecularGreen Fluorescent ProteinsHumansIslet Amyloid PolypeptideMicePeptide FragmentsPeptidesProtein BindingProtein FoldingProtein MultimerizationProtein Structure, QuaternaryProtein Structure, SecondaryProtein Structure, TertiaryProteinsalpha-Synucleinbeta 2-Microglobulin